JASPER THERAPEUTICS, INC.
Last · —$0.501+0.005 (+1.01%)live · yahoo · 0s ago
Vol 620.1K ≈ 310.7K
MA10MA20MA50
Market cap$16.67M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameJASPER THERAPEUTICS, INC.
HQUnited States (US)
ListingUS JSPR
ISINUS4718712023
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001788028
CIK0001788028
Websitewww.jaspertherapeutics.com
Employees22
AddressJasper Therapeutics, Inc. 2200 Bridge Parkway 94065, Redwood City
Loading chart…
Upcoming earnings
TUE.10NOV
8:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.56
Est. revenue
0
Press & signals
- Satelight
Zafira–A dual-mode language bridging Python agility and native C safety
- GlobeNewswire
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
- GlobeNewswire
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags
Showing 5 of 10 filings